Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Alessandro Tomelleri, Corrado Campochiaro, Giacomo De Luca, Nicola Farina, Giulio Cavalli & Lorenzo Dagna. (2021) Canakinumab injection for the treatment of active Still’s disease, including adult-onset Still’s disease. Expert Opinion on Orphan Drugs 9:3, pages 77-86.
Read now
Read now
Paolo Sfriso, Sara Bindoli, Andrea Doria, Eugen Feist & Paola Galozzi. (2020) Canakinumab for the treatment of adult-onset Still’s disease. Expert Review of Clinical Immunology 16:2, pages 129-138.
Read now
Read now
Rajkumar Ganesan, Ernest L. Raymond, Detlev Mennerich, Joseph R. Woska$suffix/text()$suffix/text(), Gary Caviness, Christine Grimaldi, Jennifer Ahlberg, Rocio Perez, Simon Roberts, Danlin Yang, Kavita Jerath, Kristopher Truncali, Lee Frego, Eliud Sepulveda, Priyanka Gupta, Su-Ellen Brown, Michael D. Howell, Keith A. Canada, Rachel Kroe-Barrett, Jay S. Fine, Sanjaya Singh & M. Lamine Mbow. (2017) Generation and functional characterization of anti-human and anti-mouse IL-36R antagonist monoclonal antibodies. mAbs 9:7, pages 1143-1154.
Read now
Read now
Emmanuelle C. Landmann & Ulrich A. Walker. (2017) Pharmacological treatment options for cryopyrin-associated periodic syndromes. Expert Review of Clinical Pharmacology 10:8, pages 855-864.
Read now
Read now
Articles from other publishers (42)
Matthew Kazaleh, Rachel Gioscia-Ryan, Gorav Ailawadi & Morgan Salmon. (2023) Oxidative Stress and the Pathogenesis of Aortic Aneurysms. Biomedicines 12:1, pages 3.
Crossref
Crossref
Ulrich Hommel, Konstanze Hurth, Jean-Michel Rondeau, Anna Vulpetti, Daniela Ostermeier, Andreas Boettcher, Jacob Peter Brady, Michael Hediger, Sylvie Lehmann, Elke Koch, Anke Blechschmidt, Rina Yamamoto, Valentina Tundo Dottorello, Sandra Haenni-Holzinger, Christian Kaiser, Philipp Lehr, Andreas Lingel, Luca Mureddu, Christian Schleberger, Jutta Blank, Paul Ramage, Felix Freuler, Joerg Eder & Frédéric Bornancin. (2023) Discovery of a selective and biologically active low-molecular weight antagonist of human interleukin-1β. Nature Communications 14:1.
Crossref
Crossref
Qingwen Meng, Huajiang Liu, Jinteng Liu, Yangyang Pang & Qibing Liu. (2023) Advances in immunotherapy modalities for atherosclerosis. Frontiers in Pharmacology 13.
Crossref
Crossref
Rebecca C. Coll. 2023. Inflammasome Biology. Inflammasome Biology
583
603
.
Yu-Chyi Hwang, Ruei-Min Lu, Shih-Chieh Su, Pao-Yin Chiang, Shih-Han Ko, Feng-Yi Ke, Kang-Hao Liang, Tzung-Yang Hsieh & Han-Chung Wu. (2022) Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection. Journal of Biomedical Science 29:1.
Crossref
Crossref
Brad Screnci, Lewis J. Stafford, Trevor Barnes, Kristen Shema, Samantha Gilman, Rebecca Wright, Suzie Al Absi, Tim Phillips, Charles Azuelos, Katherine Slovik, Paige Murphy, Daniel B. Harmon, Tom Charpentier, Benjamin J. Doranz, Joseph B. Rucker & Ross Chambers. (2022) Antibody specificity against highly conserved membrane protein Claudin 6 driven by single atomic contact point. iScience 25:12, pages 105665.
Crossref
Crossref
Alba García-Fernández, Gema Vivo-Llorca, Mónica Sancho, Alicia García-Jareño, Laura Ramírez-Jiménez, Eloísa Barber-Cano, José Murguía, Mar Orzáez, Félix Sancenón & Ramón Martínez-Máñez. (2022) Nanodevices for the Efficient Codelivery of CRISPR-Cas9 Editing Machinery and an Entrapped Cargo: A Proposal for Dual Anti-Inflammatory Therapy. Pharmaceutics 14:7, pages 1495.
Crossref
Crossref
Thomas Hoyler, Bettina Bannert, Cédric André, Damian Beck, Thomas Boulay, David Buffet, Nadja Caesar, Thomas Calzascia, Janet Dawson, Diego Kyburz, Robert Hennze, Christine Huppertz, Amanda Littlewood-Evans, Pius Loetscher, Kirsten D. Mertz, Satoru Niwa, Gautier Robert, James S. Rush, Giulia Ruzzante, Sophie Sarret, Thomas Stein, Ismahane Touil, Grazyna Wieczorek, Geraldine Zipfel, Stuart Hawtin & Tobias Junt. (2022) Nonhematopoietic IRAK1 drives arthritis via neutrophil chemoattractants. JCI Insight 7:13.
Crossref
Crossref
Soheila Montazersaheb, Seyed Mahdi Hosseiniyan Khatibi, Mohammad Saeid Hejazi, Vahideh Tarhriz, Afsaneh Farjami, Faramarz Ghasemian Sorbeni, Raheleh Farahzadi & Tohid Ghasemnejad. (2022) COVID-19 infection: an overview on cytokine storm and related interventions. Virology Journal 19:1.
Crossref
Crossref
Louise Goksøyr, Anders B. Funch, Anna K. Okholm, Thor G. Theander, Willem Adriaan de Jongh, Charlotte M. Bonefeld & Adam F. Sander. (2022) Preclinical Efficacy of a Capsid Virus-like Particle-Based Vaccine Targeting IL-1β for Treatment of Allergic Contact Dermatitis. Vaccines 10:5, pages 828.
Crossref
Crossref
Anouar Hafiane & Stella S. Daskalopoulou. (2022) Targeting the residual cardiovascular risk by specific anti-inflammatory interventions as a therapeutic strategy in atherosclerosis. Pharmacological Research 178, pages 106157.
Crossref
Crossref
Afsaneh Farjami, Soheila Montazersaheb, SaiedehRazi Soofiyani, Parvin Akbarzadehlaleh & Sara Salatin. (2022) Biopharmaceuticals for prevention of COVID-19: A scoping review. Asian Pacific Journal of Tropical Medicine 15:6, pages 245.
Crossref
Crossref
Ashim Malhotra. 2022. Macrophage Targeted Delivery Systems. Macrophage Targeted Delivery Systems
517
527
.
Yanfang P. Zhu, Isaac Shamie, Jamie C. Lee, Cameron J. Nowell, Weiqi Peng, Shiela Angulo, Linh N.N. Le, Yushan Liu, Huilai Miao, Hainan Xiong, Cathleen J. Pena, Elizabeth Moreno, Eric Griffis, Stephanie G. Labou, Alessandra Franco, Lori Broderick, Hal M. Hoffman, Chisato Shimizu, Nathan E. Lewis, John T. Kanegaye, Adriana H. Tremoulet, Jane C. Burns & Ben A. Croker. (2021) Immune response to intravenous immunoglobulin in patients with Kawasaki disease and MIS-C. Journal of Clinical Investigation 131:20.
Crossref
Crossref
Katia Falasca, Myriam Di Penta, Claudio Ucciferri, Antonio Auricchio, Marta Di Nicola, Michele Marchioni, Eleonora Celletti, Emanuela Sabatini, Francesco Cipollone & Jacopo Vecchiet. (2021) Efficacy of canakinumab in mild or severe COVID‐19 pneumonia. Immunity, Inflammation and Disease 9:2, pages 399-405.
Crossref
Crossref
Gaurav Doshi & Ami Thakkar. (2021) Deciphering Role of Cytokines for Therapeutic Strategies Against Rheumatoid Arthritis. Current Drug Targets 22:7, pages 803-815.
Crossref
Crossref
Pilar Garrido, Jean-Louis Pujol, Edward S Kim, Jay M Lee, Masahiro Tsuboi, Ana Gómez-Rueda, Amparo Benito, Nicolas Moreno, Luis Gorospe, Tuochuan Dong, Cecile Blin, Vanessa Rodrik-Outmezguine, Vanessa Q Passos & Tony SK Mok. (2021) Canakinumab with and without pembrolizumab in patients with resectable non-small-cell lung cancer: CANOPY-N study design. Future Oncology 17:12, pages 1459-1472.
Crossref
Crossref
Wen-Chih Kuo, Cheng-Chung Lee, Ya-Wen Chang, Wei Pang, Hong-Sen Chen, Shin-Chen Hou, Shin-Yi Lo, An-Suei Yang & Andrew H.-J. Wang. (2021) Structure-based Development of Human Interleukin-1β-Specific Antibody That Simultaneously Inhibits Binding to Both IL-1RI and IL-1RAcP. Journal of Molecular Biology 433:4, pages 166766.
Crossref
Crossref
Luca Liberale, Fabrizio Montecucco, Lena Schwarz, Thomas F Lüscher & Giovanni G Camici. (2021) Inflammation and cardiovascular diseases: lessons from seminal clinical trials. Cardiovascular Research 117:2, pages 411-422.
Crossref
Crossref
Antonio Mastroianni, Sonia Greco, Luciana Chidichimo, Filippo Urso, Francesca Greco, Maria V Mauro & Valeria Vangeli. (2021) Early use of canakinumab to prevent mechanical ventilation in select COVID-19 patients: A retrospective, observational analysis. International Journal of Immunopathology and Pharmacology 35, pages 205873842110596.
Crossref
Crossref
Erdal Sag, Fuat Akal, Erdal Atalay, Ummusen Kaya Akca, Selcan Demir, Dilara Demirel, Ezgi Deniz Batu, Yelda Bilginer & Seza Ozen. (2020) Anti-IL1 treatment in colchicine-resistant paediatric FMF patients: real life data from the HELIOS registry. Rheumatology 59:11, pages 3324-3329.
Crossref
Crossref
Ana Ferrero-Andrés, Arnau Panisello-Roselló, Joan Roselló-Catafau & Emma Folch-Puy. (2020) NLRP3 Inflammasome-Mediated Inflammation in Acute Pancreatitis. International Journal of Molecular Sciences 21:15, pages 5386.
Crossref
Crossref
Hermann Gram. (2020) The long and winding road in pharmaceutical development of canakinumab from rare genetic autoinflammatory syndromes to myocardial infarction and cancer. Pharmacological Research 154, pages 104139.
Crossref
Crossref
Samantha J. Allen & Kevin J. Lumb. 2020.
253
303
.
Chaelin Lee, Hien Thi Thu Do, Junhyeok Her, Yeonjae Kim, Dongkyu Seo & Inmoo Rhee. (2019) Inflammasome as a promising therapeutic target for cancer. Life Sciences 231, pages 116593.
Crossref
Crossref
Mary Linge, Christian M. Hedrich, Angela Rösen-Wolff & Stefan Winkler. (2019) Interference of canakinumab with commercial IL-1β ELISAs. Clinical Immunology.
Crossref
Crossref
Kurt T. K. Giuliani, Andrew J. Kassianos, Helen Healy & Pedro H. F. Gois. (2019) Pigment Nephropathy: Novel Insights into Inflammasome-Mediated Pathogenesis. International Journal of Molecular Sciences 20:8, pages 1997.
Crossref
Crossref
E. L. Nasonov. (2019) The role of interleukin 1 in the development of human diseases. Rheumatology Science and Practice 56, pages 19-27.
Crossref
Crossref
Ting Liu, Qingxuan Zeng, Xiaoqiang Zhao, Wei Wei, Yinghong Li, Hongbin Deng & Danqing Song. (2019) Synthesis and Biological Evaluation of Fangchinoline Derivatives as Anti-Inflammatory Agents through Inactivation of Inflammasome. Molecules 24:6, pages 1154.
Crossref
Crossref
Lisa Kraft, Tugs Erdenesukh, Martina Sauter, Carsten Tschöpe & Karin Klingel. (2019) Blocking the IL-1β signalling pathway prevents chronic viral myocarditis and cardiac remodeling. Basic Research in Cardiology 114:2.
Crossref
Crossref
Adi Litmanovich, Khaled Khazim & Idan Cohen. (2018) The Role of Interleukin-1 in the Pathogenesis of Cancer and its Potential as a Therapeutic Target in Clinical Practice. Oncology and Therapy 6:2, pages 109-127.
Crossref
Crossref
Xiaobing Li, William J. Jusko & Yanguang Cao. (2018) Role of Interstitial Fluid Turnover on Target Suppression by Therapeutic Biologics Using a Minimal Physiologically Based Pharmacokinetic Model. Journal of Pharmacology and Experimental Therapeutics 367:1, pages 1-8.
Crossref
Crossref
I A Clark & B Vissel. (2018) Therapeutic implications of how TNF links apolipoprotein E, phosphorylated tau, α‐synuclein, amyloid‐β and insulin resistance in neurodegenerative diseases. British Journal of Pharmacology 175:20, pages 3859-3875.
Crossref
Crossref
Paola Galozzi, Chiara Baggio, Sara Bindoli, Francesca Oliviero & Paolo Sfriso. (2018) Development and Role in Therapy of Canakinumab in Adult-Onset Still’s Disease. Frontiers in Pharmacology 9.
Crossref
Crossref
Kristine A. Smith, Abigail Pulsipher, David A. Gabrielsen & Jeremiah A. Alt. (2018) Biologics in Chronic Rhinosinusitis: An Update and Thoughts for Future Directions. American Journal of Rhinology & Allergy 32:5, pages 412-423.
Crossref
Crossref
Guillermo García-Laínez, Mónica Sancho, Vanessa García-Bayarri & Mar Orzáez. (2017) Identification and validation of uterine stimulant methylergometrine as a potential inhibitor of caspase-1 activation. Apoptosis 22:10, pages 1310-1318.
Crossref
Crossref
Ian A. Clark & Bryce Vissel. (2017) The meteorology of cytokine storms, and the clinical usefulness of this knowledge. Seminars in Immunopathology 39:5, pages 505-516.
Crossref
Crossref
Franziska Dahlmann & Katherina Sewald. (2017) Use of nonhuman primates in obstructive lung disease research – is it required?. Primate Biology 4:1, pages 131-142.
Crossref
Crossref
Elísabet Alcocer-Gómez, Beatriz Castejón-Vega & Mario D. Cordero. 2017. Stress and Inflammation in Disorders. Stress and Inflammation in Disorders
127
162
.
P. Ellul, L. Boyer, L. Groc, M. Leboyer & G. Fond. (2016) Interleukin‐1 β‐targeted treatment strategies in inflammatory depression: toward personalized care. Acta Psychiatrica Scandinavica 134:6, pages 469-484.
Crossref
Crossref
Amanda Littlewood-Evans, Sophie Sarret, Verena Apfel, Perrine Loesle, Janet Dawson, Juan Zhang, Alban Muller, Bruno Tigani, Rainer Kneuer, Saijel Patel, Stephanie Valeaux, Nina Gommermann, Tina Rubic-Schneider, Tobias Junt & José M. Carballido. (2016) GPR91 senses extracellular succinate released from inflammatory macrophages and exacerbates rheumatoid arthritis. Journal of Experimental Medicine 213:9, pages 1655-1662.
Crossref
Crossref
Hermann Gram. (2016) Preclinical characterization and clinical development of ILARIS® (canakinumab) for the treatment of autoinflammatory diseases. Current Opinion in Chemical Biology 32, pages 1-9.
Crossref
Crossref